Neurotech Pharmaceuticals Lands $15,000,000 Series B Round

  • Feed Type
  • Date
    10/22/2008
  • Company Name
    Neurotech Pharmaceuticals
  • Mailing Address
    6 Blackstone Valley Place Lincoln, RI 02865
  • Company Description
    Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in ophthalmology.
  • Website
    http://www.neurotechusa.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.